Table 2 Factors affecting the liver abscess formation
Characteristics (N = 127) | Liver abscess (+) (N = 10) | Liver abscess (−) (N = 117) | OR, 95% CI | p value* |
|---|---|---|---|---|
Patient demographics | ||||
Male gender | 7 (70) | 73 (62) | 1.41, 0.35–5.72 | 0.633 |
Age ≥ 65 years | 8 (80) | 86 (74) | 1.44, 0.29–7.16 | 0.653 |
Community-onset BSIs | 10 (100) | 62 (53) | N/A | 0.004 |
Underlying disease | ||||
Biliary tract disease | 2 (20) | 29 (25) | 0.76, 0.15–3.78 | 0.735 |
Diabetes mellitus | 3 (30) | 35 (30) | 1.00, 0.25–4.11 | 0.996 |
Malignancy | ||||
Hematologic | 0 (0) | 10 (9) | 0 | 0.335 |
Solid organ | 2 (20) | 33 (28) | 0.64, 0.13–3.15 | 0.577 |
Other | 2 (20) | 29 (25) | 0.76, 0.15–3.78 | 0.735 |
None | 2 (20) | 3 (3) | 9.5, 1.38–65.28 | 0.007 |
30-day mortality (n = 120) | 3 (30) | 20 (18) | 0.68, 0.17–2.79 | 0.363 |
Bacterial phenotypes | ||||
Capsular serotype K1 | 5 (50) | 7 (6) | 15.71, 3.66–67.40 | < 0.0001 |
Capsular serotype K2 | 0 (0) | 18 (16) | 0 | 0.181 |
Hypermucoviscosity | 5 (50) | 12 (10) | 8.75, 2.21–34.64 | 0.0004 |
ESBL-producer | 0 (0) | 8 (7) | 0 | 0.393 |